Senores Pharmaceuticals Limited (NSE:SENORES)

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Pharmaceuticals	3.98B	2.15B	353.37M	141.70M
Pharmaceuticals Growth	85.65%	507.07%	149.38%	-
Total	3.98B	2.15B	353.37M	141.70M
Total Growth	85.65%	507.07%	149.38%	-

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
India	1.05B	474.30M	55.09M	58.33M
India Growth	121.21%	760.95%	-5.55%	-
outside India	2.93B	1.67B	298.28M	83.37M
outside India Growth	75.55%	460.18%	257.78%	-
Total	3.98B	2.15B	353.37M	141.70M
Total Growth	85.65%	507.07%	149.38%	-

Source: S&P Global Market Intelligence.